Mirabegron: pharmacoeconomic aspects of the use of the drug for the treatment of overactive bladder syndrome

• Main Authors: O. I. Ivakhnenko (Author), E. V. Derkach (Author), V. S. Krysanova (Author), A. D. Ermolaeva (Author), K. A. Kokushkin (Author)
• Format: Book
• Published: Izdatelstvo OKI, 2022-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

According to the International Continence Society (ICS), symptoms of overactive bladder (OAB) are present in 17 % of the adult population of Europe. The prevalence of overactive bladder in Russia is unknown but is considered comparable to that in European countries. According to Russian guidelines,...